They termed it "mycotic pseudotuberculosis", now known as allergic bronchopulmonary aspergillosis.

Hypersensitivity may also be a reaction toward an established fungal infection in allergic bronchopulmonary aspergillosis.

Symptoms of allergic bronchopulmonary aspergillosis may include:

One kind is allergic bronchopulmonary aspergillosis (also called ABPA).

The most common forms are allergic bronchopulmonary aspergillosis, pulmonary aspergilloma, and invasive aspergillosis.

Among these is allergic bronchopulmonary aspergillosis, in which the body's response to the common fungus Aspergillus fumigatus causes worsening of breathing problems.

At this time, they are recommended only for people who have significant shortness of breath and wheezing or an infection caused by a fungus (allergic bronchopulmonary aspergillosis).

Patients with allergic bronchopulmonary aspergillosis often have symptoms of poorly controlled asthma, with wheezing, cough, shortness of breath and exercise intolerance.

Four main clinical types of aspergillosis are usually identified - allergic bronchopulmonary aspergillosis, aspergilloma, invasive aspergillosis, and chronic necrotizing aspergillosis.

Allergic bronchopulmonary aspergillosis (ABPA) is a disorder that affects the airways of the lungs which is caused by an allergic hypersensitivity to the fungus Aspergillus fumigatus.

One kind is allergic bronchopulmonary aspergillosis (also called ABPA), a condition where the fungus causes allergic respiratory symptoms, such as wheezing and coughing, but does not actually invade and destroy tissue.

Other acquired causes of bronchiectasis involving environmental exposures include respiratory infections, obstructions, inhalation and aspiration of ammonia and other toxic gases, pulmonary aspiration, alcoholism, heroin (drug use), various allergies, and allergic bronchopulmonary aspergillosis.

Kubba and Young have pointed out a number of other conceivable, if unlikely, diagnoses, besides cystic fibrosis and alfa 1-antitripsin deficiency: Churg-Strauss syndrome, allergic bronchopulmonary aspergillosis, hypogammaglobulinemia, idiopathic pulmonary haemosiderosis, lung abscesses, and pulmonary arteriovenous malformations.

Dr. Gary Cutting, a molecular geneticist at Johns Hopkins University, is starting to find cystic fibrosis mutations in two groups of patients, those with a frequent complication of asthma known as allergic bronchopulmonary aspergillosis and those with a common manifestation of chronic bronchitis called chronic pseudomonas bronchitis.

They termed it "mycotic pseudotuberculosis", now known as allergic bronchopulmonary aspergillosis.

Hypersensitivity may also be a reaction toward an established fungal infection in allergic bronchopulmonary aspergillosis.

Symptoms of allergic bronchopulmonary aspergillosis may include:

One kind is allergic bronchopulmonary aspergillosis (also called ABPA).

The most common forms are allergic bronchopulmonary aspergillosis, pulmonary aspergilloma, and invasive aspergillosis.

Among these is allergic bronchopulmonary aspergillosis, in which the body's response to the common fungus Aspergillus fumigatus causes worsening of breathing problems.

At this time, they are recommended only for people who have significant shortness of breath and wheezing or an infection caused by a fungus (allergic bronchopulmonary aspergillosis).

Patients with allergic bronchopulmonary aspergillosis often have symptoms of poorly controlled asthma, with wheezing, cough, shortness of breath and exercise intolerance.

Four main clinical types of aspergillosis are usually identified - allergic bronchopulmonary aspergillosis, aspergilloma, invasive aspergillosis, and chronic necrotizing aspergillosis.

Allergic bronchopulmonary aspergillosis (ABPA) is a disorder that affects the airways of the lungs which is caused by an allergic hypersensitivity to the fungus Aspergillus fumigatus.

One kind is allergic bronchopulmonary aspergillosis (also called ABPA), a condition where the fungus causes allergic respiratory symptoms, such as wheezing and coughing, but does not actually invade and destroy tissue.

Other acquired causes of bronchiectasis involving environmental exposures include respiratory infections, obstructions, inhalation and aspiration of ammonia and other toxic gases, pulmonary aspiration, alcoholism, heroin (drug use), various allergies, and allergic bronchopulmonary aspergillosis.

Kubba and Young have pointed out a number of other conceivable, if unlikely, diagnoses, besides cystic fibrosis and alfa 1-antitripsin deficiency: Churg-Strauss syndrome, allergic bronchopulmonary aspergillosis, hypogammaglobulinemia, idiopathic pulmonary haemosiderosis, lung abscesses, and pulmonary arteriovenous malformations.

Dr. Gary Cutting, a molecular geneticist at Johns Hopkins University, is starting to find cystic fibrosis mutations in two groups of patients, those with a frequent complication of asthma known as allergic bronchopulmonary aspergillosis and those with a common manifestation of chronic bronchitis called chronic pseudomonas bronchitis.